1. Home
  2. CYBN vs TCPC Comparison

CYBN vs TCPC Comparison

Compare CYBN & TCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cybin Inc.

CYBN

Cybin Inc.

HOLD

Current Price

$8.28

Market Cap

416.1M

Sector

Health Care

ML Signal

HOLD

Logo BlackRock TCP Capital Corp.

TCPC

BlackRock TCP Capital Corp.

HOLD

Current Price

$5.58

Market Cap

449.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYBN
TCPC
Founded
2019
2006
Country
Canada
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
416.1M
449.7M
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
CYBN
TCPC
Price
$8.28
$5.58
Analyst Decision
Strong Buy
Sell
Analyst Count
4
2
Target Price
$74.50
$6.50
AVG Volume (30 Days)
916.5K
1.0M
Earning Date
02-10-2026
11-06-2025
Dividend Yield
N/A
21.98%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$219,119,058.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.81
$5.29
52 Week High
$10.73
$9.48

Technical Indicators

Market Signals
Indicator
CYBN
TCPC
Relative Strength Index (RSI) 68.97 44.70
Support Level $7.85 $5.29
Resistance Level $9.12 $5.76
Average True Range (ATR) 0.51 0.15
MACD 0.15 -0.01
Stochastic Oscillator 68.59 33.73

Price Performance

Historical Comparison
CYBN
TCPC

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

About TCPC BlackRock TCP Capital Corp.

BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights or direct equity investments.

Share on Social Networks: